- People suffering from leptin or insulin resistance – diabetics, overweighed people and people with high cholesterol should limit their fruit intake. In fact, their daily fructose intake shouldn’t go over 15 grams.
- People with normal weight and not any health issues as in 1# should eat fruit on a regular daily basis, especially after working out because then, the body uses this sugar as fuel thus preventing the increase of blood sugar levels.
Diabetes drugs
Metformin, one of the most common diabetes drugs, has been linked to higher risk of low levels thyroid-stimulating hormone – TSH. On the other hand, low TSH affects overall health and leads to cardiovascular issues such as atrial fibrillation, which can result in congestive heart failure. New research found that treating type 3 diabetes with prescription drugs reduces blood glucose levels, but drastically increases the risk of death from heart-related diseases.
Beta-blockers and Scientific Misconduct
It’s known that beta-blockers prevent the neurotransmitters epinephrine (adrenaline) and norepinephrine from binding to beta receptors. Although these blockers are commonly given to patients who don’t need a heart surgery, statistics shows beta-blockers have caused death in nearly 800,000 in Europe only.
You need to protect your heart
- Reduce exposure to stress and anxiety.
- Avoid sitting for too long.
- Avoid statins, as they produce unwanted side effects.
- Increase your intake of unprocessed saturated animal fats.
- Cut out sugars, including grains and processed fructose.
- Exercise regularly: weight-lifting, high-intensity interval training, core workout and stretching.
- Increase your vitamin D intake. Spend more time in the sun or simply take vitamin D supplements.
- Walk barefoot to get some potent antioxidants from the earth. When these antioxidants are carried through the free electrons, they relieve inflammation in the body.
imfinzi immunotherapy,best treatment for small cell lung cancer,small cell lung carcinoma treatment,egfr exon 20 treatment,small cell lung cancer chemotherapy regimens,side effects of immunotherapy for small cell lung cancer,nsclc treatment options,chemo for small cell lung cancer,immunotherapy for lung cancer stage 3,non small lung cancer treatment,stage 3b lung cancer treatment,chemo for lung cancer stage 3,non small cell lung cancer medications,metastatic nsclc treatment,sclc chemotherapy,small cell carcinoma treatment,sclc treatment,non small cell lung cancer treatment options,stage 3 lung cancer treatment,immunotherapy in small cell lung cancer,osimertinib adjuvant fda approval,nsclc immunotherapy,met lung cancer treatment,stage 3 lung cancer immunotherapy,cure for silicosis,sclc immunotherapy,small cell carcinoma chemotherapy,medical treatment for lung cancer,nsclc treatment,nsclc therapy,small cell lung cancer chemotherapy,met mutation lung cancer treatment,non small cell lung cancer treatment,small cell lung cancer treatment,immunotherapy for small cell lung cancer,lung cancer targeted therapy survival,chemotherapy for lung cancer stage 3,immunotherapy for non small cell lung cancer,nsclc targeted therapy,new treatment for small cell lung cancer,osimertinib immunotherapy,radiation for lung cancer stage 3,autoimmune therapy for lung cancer,nsclc first line treatment,small cell lung cancer new treatment 2020,small cell lung cancer treatment options,targeted drug therapy for lung cancer,small lung cancer treatment,new drug for small cell lung cancer,small cell lung cancer targeted therapy,non small cell lung cancer targeted therapy,egfr nsclc treatment,immunotherapy for lung cancer,immunotherapy treatment for lung cancer,new immunotherapy for lung cancer,osimertinib pneumonitis,egfr osimertinib,nsclc medical,radiation for small cell lung cancer,nsclc chemotherapy regimens,targeted therapy for lung cancer,metastatic lung cancer treatment,stage 4 lung cancer treatment options,immunotherapy for stage 4 lung cancer,targeted therapy for lung cancer stage 4,osimertinib astrazeneca,keytruda stage 4 lung cancer,stage 4 non small cell lung cancer treatment,neoadjuvant chemotherapy lung cancer,treatment for lung cancer stage 4,stage four lung cancer treatment,chemo pill for lung cancer,new treatments for lung cancer stage 4,osimertinib chemotherapy,osimertinib first line,kras lung cancer immunotherapy,immunology treatment for lung cancer,targeted treatment for lung cancer,lung cancer pill treatment,stage 4 small cell lung cancer prognosis,stage iv lung cancer treatment,stage 3a non small cell lung cancer,small cell lung cancer surgery,non small cell lung cancer radiation therapy,immunotherapy for lung cancer 2020,lung cancer medicine,advanced lung cancer treatment,immunotherapy for metastatic lung cancer,latest lung cancer treatment,non small cell lung cancer chemotherapy,adjuvant immunotherapy lung cancer,nsclc chemotherapy,chemo and immunotherapy for lung cancer,silicosis natural treatment,pdl1 lung cancer treatment,kras mutation lung cancer treatment,types of immunotherapy for lung cancer,stage 4 nsclc prognosis,lung metastasis treatment,stage 3a lung cancer without treatment
